MECHANISMS OF ACID RESISTANCE IN BARRETT'S ESOPHAGUS
Project Number7R01DK063669-06
Contact PI/Project LeaderORLANDO, ROY CHARLES
Awardee OrganizationUNIV OF NORTH CAROLINA CHAPEL HILL
Description
Abstract Text
DESCRIPTION (provided by applicant): Barrett's esophagus denotes the presence of specialized columnar epithelium (SCE) in distal esophagus. It develops in subjects with acid reflux disease as replacement for destroyed esophageal stratified squamous epithelium (ESSE). In 90%, it remains stable for life and irrespective of treatment since most - presumably because of its acid resistance - are (reflux) symptom-free. In one sense, then, Barrett's is a successful adaptation for esophageal protection. Barrett's, however, has a high cell turnover rate which establishes it as a premalignant lesion that increases esophageal cancer risk 40-fold over the general population. Though clinically important, little is known about the biology of SCE, and specifically about the mechanisms for acid resistance that are at the heart of its very existence. Therefore the goals of this proposal are: a) to define the preepithelial and epithelial mechanisms for SCE's survival under acidic stress: b) compare them to ESSE in Barrett's in order to test the hypothesis that SCE develops in GERD because of intrinsic mechanisms that make it more acid resistant than ESSE, and c) since alcohol and cigarette smoking increase the risk of malignancy in SCE, test the hypothesis that this risk reflects the ability of these agents to shorten cell survival I (which increases cell turnover) by impairing SCE's ability to protect itself under an acidic stress. The specific aims are to determine in SCE and ESSE in Barrett s: 1) the magnitude of the lumen-to-surface pH gradient and role of mucus and HCO3, 2) the permeability of the apical membrane-junctional complex to H+, 3) the total cell buffer capacity and role of carbonic anhydrase, 4) the nature, location and activity of transporters for pHi regulation, 5) the effect of alcohol and smoking on cell survival under an acid stress, and to: 6) compare the results to ESSE in those without esophageal disease. Studies are performed using esophageal biopsies for cell isolation, culture and mounting in mini-Ussing chambers. Techniques include: pH icroelectrodes, immunohistochemistry, impedance analysis and fluorescence microscopy. Achievement of the proposed goals will yield information of fundamental importance to understanding the pathogenesis and malignant potential of SCE in reflux subjects and provide insights into possible novel strategies for its prevention, stabilization or selective eradication for reduction of cancer risk.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
848
DUNS Number
608195277
UEI
D3LHU66KBLD5
Project Start Date
30-September-2002
Project End Date
31-May-2009
Budget Start Date
01-July-2007
Budget End Date
31-May-2009
Project Funding Information for 2006
Total Funding
$144,086
Direct Costs
$98,689
Indirect Costs
$45,397
Year
Funding IC
FY Total Cost by IC
2006
National Institute of Diabetes and Digestive and Kidney Diseases
$144,086
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 7R01DK063669-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 7R01DK063669-06
Patents
No Patents information available for 7R01DK063669-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 7R01DK063669-06
Clinical Studies
No Clinical Studies information available for 7R01DK063669-06
News and More
Related News Releases
No news release information available for 7R01DK063669-06
History
No Historical information available for 7R01DK063669-06
Similar Projects
No Similar Projects information available for 7R01DK063669-06